Amal Fawzy

555 total citations
26 papers, 458 citations indexed

About

Amal Fawzy is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Amal Fawzy has authored 26 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cancer Research, 13 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Amal Fawzy's work include Circular RNAs in diseases (9 papers), MicroRNA in disease regulation (7 papers) and Cancer-related molecular mechanisms research (6 papers). Amal Fawzy is often cited by papers focused on Circular RNAs in diseases (9 papers), MicroRNA in disease regulation (7 papers) and Cancer-related molecular mechanisms research (6 papers). Amal Fawzy collaborates with scholars based in Egypt, India and Saudi Arabia. Amal Fawzy's co-authors include Ahmed I. Abulsoud, Azza M. Kamel, Tamer Elbaz, Sherif Hamdy, Omar Ahmad, Nadia Μ. Hamdy, Ahmed Ismail, Hanan Elimam, Sherine M. Rizk and Mai A. Abd‐Elmawla and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Materials.

In The Last Decade

Amal Fawzy

24 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amal Fawzy Egypt 12 296 275 78 60 50 26 458
Samson Mani India 13 246 0.8× 372 1.4× 92 1.2× 39 0.7× 37 0.7× 29 522
Guoqi Song China 15 257 0.9× 358 1.3× 75 1.0× 114 1.9× 28 0.6× 30 523
Seung–Hun Shin South Korea 9 116 0.4× 233 0.8× 80 1.0× 49 0.8× 45 0.9× 14 374
Xiaojian Ni China 13 185 0.6× 263 1.0× 201 2.6× 35 0.6× 60 1.2× 34 475
Yingjun Xie China 11 366 1.2× 423 1.5× 121 1.6× 27 0.5× 76 1.5× 20 623
Susana Kofman Mexico 12 99 0.3× 270 1.0× 53 0.7× 26 0.4× 59 1.2× 23 431
Alejandro Villar‐Prados United States 7 169 0.6× 278 1.0× 52 0.7× 23 0.4× 23 0.5× 12 374
Ivana Fridrichová Slovakia 14 331 1.1× 438 1.6× 158 2.0× 74 1.2× 35 0.7× 35 610
Andy Goberdhan United States 5 111 0.4× 346 1.3× 202 2.6× 40 0.7× 58 1.2× 7 535

Countries citing papers authored by Amal Fawzy

Since Specialization
Citations

This map shows the geographic impact of Amal Fawzy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amal Fawzy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amal Fawzy more than expected).

Fields of papers citing papers by Amal Fawzy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amal Fawzy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amal Fawzy. The network helps show where Amal Fawzy may publish in the future.

Co-authorship network of co-authors of Amal Fawzy

This figure shows the co-authorship network connecting the top 25 collaborators of Amal Fawzy. A scholar is included among the top collaborators of Amal Fawzy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amal Fawzy. Amal Fawzy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fawzy, Amal, et al.. (2025). Preliminary Evaluation of Plasma circ_0009910, circ_0027478, and miR-1236-3p as Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma. International Journal of Molecular Sciences. 26(10). 4842–4842.
3.
Zaki, Mohamed Bakr, Mai A. Abd‐Elmawla, Hanan Elimam, et al.. (2023). Telomerase RNA component lncRNA as potential diagnostic biomarker promotes CRC cellular migration and apoptosis evasion via modulation of β-catenin protein level. Non-coding RNA Research. 8(3). 302–314. 50 indexed citations
4.
Abulsoud, Ahmed I., et al.. (2023). LncRNA NNT-AS1/hsa-miR-485–5p/HSP90 axis in-silico and clinical prospect correlated-to histologic grades-based CRC stratification: A step toward ncRNA Precision. Pathology - Research and Practice. 247. 154570–154570. 41 indexed citations
5.
6.
Abulsoud, Ahmed I., et al.. (2023). The long non-coding RNA ZFAS1 promotes colorectal cancer progression via miR200b/ZEB1 axis. Pathology - Research and Practice. 247. 154567–154567. 29 indexed citations
7.
Elshami, Ahmed A., et al.. (2022). Behaviour of sustainable concretes modified with mineral admixtures and Nano-silica against aggressive media attacks. IOP Conference Series Earth and Environmental Science. 1026(1). 12052–12052. 1 indexed citations
8.
Fawzy, Amal, et al.. (2021). Regulation of CDK inhibitor p27 by microRNA 222 in breast cancer patients. Experimental and Molecular Pathology. 123. 104718–104718. 10 indexed citations
9.
Ismail, Ahmed, et al.. (2018). Diagnostic Significance of miR-639 and miR-10b in Βreast Cancer Patients. Meta Gene. 19. 155–159. 31 indexed citations
10.
Fawzy, Amal, et al.. (2018). Evaluation of cell free circulating plasma DNA in prostate cancer. 34(1). 108–122. 1 indexed citations
11.
Youssef, Omar, et al.. (2018). Expression of Plasma miRNA-221 in Colorectal Carcinoma Patients and its Diagnostic Significance in Comparison with p53 Expression. Clinical Laboratory. 64(09/2018). 1527–1533. 2 indexed citations
12.
Fawzy, Amal, et al.. (2018). Efficient Implementation of SC-FDMA with PAPR Reduction and Channel equalization. 27(1). 89–108. 1 indexed citations
13.
Fawzy, Amal, et al.. (2016). Increased Serum Endoglin and Transforming Growth Factor β1 mRNA Expression and Risk of Hepatocellular Carcinoma in Cirrhotic Egyptian Patients.. PubMed. 17(5). 2429–34. 11 indexed citations
14.
Fawzy, Amal, et al.. (2016). Quantitative analysis of plasma cell-free DNA and its DNA integrity in patients with metastatic prostate cancer using ALU sequence. Journal of the Egyptian National Cancer Institute. 28(4). 235–242. 43 indexed citations
15.
Fawzy, Amal, et al.. (2016). Tissue CA125 and HE4 Gene Expression Levels Offer Superior Accuracy in Discriminating Benign from Malignant Pelvic Masses. Asian Pacific Journal of Cancer Prevention. 17(1). 323–333. 14 indexed citations
16.
Kamel, Azza M., et al.. (2015). Plasma DNA integrity index as a potential molecular diagnostic marker for breast cancer. Tumor Biology. 37(6). 7565–7572. 48 indexed citations
17.
Fawzy, Amal, et al.. (2015). Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma. Tumor Biology. 37(1). 211–216. 35 indexed citations
18.
Fawzy, Amal, et al.. (2012). Importance of serum levels of angiopoietin-2 and survivin biomarkers in non-small cell lung cancer. Journal of the Egyptian National Cancer Institute. 24(1). 41–45. 29 indexed citations
19.
Fawzy, Amal, et al.. (2010). The Relationship between hepatitis B Virus-X Gene, P53 gene mutation and Hepatocellular Carcinoma in HBs Ag Negative Patients with and without HCV Infection. AUSTRALIAN JOURNAL OF BASIC AND APPLIED SCIENCES. 4(1). 79–88. 2 indexed citations
20.
Fawzy, Amal, et al.. (2009). Hepcidin mRNA level as a parameter of disease progression in chronic hepatitis C and hepatocellular carcinoma.. PubMed. 21(4). 333–42. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samson Mani Breakdown of academic impact, for papers by Guoqi Song Breakdown of academic impact, for papers by Seung–Hun Shin Breakdown of academic impact, for papers by Xiaojian Ni Breakdown of academic impact, for papers by Yingjun Xie Breakdown of academic impact, for papers by Susana Kofman Breakdown of academic impact, for papers by Alejandro Villar‐Prados Breakdown of academic impact, for papers by Ivana Fridrichová Breakdown of academic impact, for papers by Andy Goberdhan
Rankless by CCL
2026